Biotricity, Inc. (BTCY)
USD 0.35
(3.83%)
USD 0.35
(3.83%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 8.35 Million USD | 53.55% |
| 2023 | 5.44 Million USD | 19.08% |
| 2022 | 4.57 Million USD | 259.08% |
| 2021 | 1.27 Million USD | 162.0% |
| 2020 | 485.77 Thousand USD | 711.45% |
| 2019 | 59.86 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 FY | 8.35 Million USD | 53.55% |
| 2024 Q1 | 1.91 Million USD | 24.89% |
| 2024 Q3 | 2.16 Million USD | 8.44% |
| 2024 Q4 | 2.27 Million USD | 4.81% |
| 2024 Q2 | 1.99 Million USD | 4.31% |
| 2023 Q3 | 1.4 Million USD | 9.51% |
| 2023 Q2 | 1.28 Million USD | 4.5% |
| 2023 FY | 5.44 Million USD | 19.08% |
| 2023 Q1 | 1.22 Million USD | -14.96% |
| 2023 Q4 | 1.53 Million USD | 9.47% |
| 2022 Q4 | 1.44 Million USD | 74.66% |
| 2022 Q3 | 824.83 Thousand USD | -27.3% |
| 2022 Q2 | 1.13 Million USD | -3.03% |
| 2022 Q1 | 1.17 Million USD | 168.16% |
| 2022 FY | 4.57 Million USD | 259.08% |
| 2021 Q1 | 250.55 Thousand USD | 810.45% |
| 2021 FY | 1.27 Million USD | 162.0% |
| 2021 Q2 | 135.28 Thousand USD | -46.0% |
| 2021 Q3 | 141.88 Thousand USD | 4.88% |
| 2021 Q4 | 436.34 Thousand USD | 207.52% |
| 2020 Q2 | 231.69 Thousand USD | 31.33% |
| 2020 Q3 | 281.11 Thousand USD | 21.33% |
| 2020 FY | 485.77 Thousand USD | 711.45% |
| 2020 Q1 | 176.41 Thousand USD | 1169.35% |
| 2020 Q4 | -35.26 Thousand USD | -112.55% |
| 2019 Q1 | 17.66 Thousand USD | 0.0% |
| 2019 FY | 59.86 Thousand USD | 0.0% |
| 2019 Q3 | 90.13 Thousand USD | 139.46% |
| 2019 Q2 | 37.64 Thousand USD | 113.15% |
| 2019 Q4 | 13.89 Thousand USD | -84.58% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acutus Medical, Inc. | -3.13 Million USD | 366.378% |
| Cerus Corporation | 86.4 Million USD | 90.328% |
| OrthoPediatrics Corp. | 111.25 Million USD | 92.489% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -1029.951% |
| Talis Biomedical Corporation | 371 Thousand USD | -2152.367% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -1.031% |
| Inogen, Inc. | 126.69 Million USD | 93.405% |
| Spectral AI, Inc. | 7.88 Million USD | -6.044% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 226.764% |
| CVRx, Inc. | 33.03 Million USD | 74.708% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -13598.821% |
| Orthofix Medical Inc. | 486.27 Million USD | 98.282% |
| Venus Concept Inc. | 52.16 Million USD | 83.982% |
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -227.697% |
| Bioventus Inc. | 328.19 Million USD | 97.454% |
| BrainsWay Ltd. | 23.09 Million USD | 63.812% |
| Envoy Medical, Inc. | -473 Thousand USD | 1866.656% |
| electroCore, Inc. | 13.22 Million USD | 36.819% |
| IceCure Medical Ltd | 1.3 Million USD | -542.791% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 238.12% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 17753.12% |
| MaxCyte, Inc. | 36.54 Million USD | 77.135% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -1730.442% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -9723.984% |
| PAVmed Inc | -3.96 Million USD | 310.592% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 252.348% |
| RxSight, Inc. | 53.76 Million USD | 84.458% |
| Sight Sciences, Inc. | 69.17 Million USD | 87.92% |
| SI-BONE, Inc. | 109.42 Million USD | 92.363% |
| TELA Bio, Inc. | 40.11 Million USD | 79.168% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | 47.465% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 94.5% |
| LivaNova PLC | 771.25 Million USD | 98.917% |
| 908 Devices Inc. | 25.32 Million USD | 67.0% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 97.306% |
| Nemaura Medical Inc. | -1.47 Million USD | 665.993% |
| NeuroPace, Inc. | 48.12 Million USD | 82.635% |
| LENSAR, Inc. | 21.1 Million USD | 60.41% |
| Apyx Medical Corporation | 14.12 Million USD | 40.828% |
| Cutera, Inc. | 41.49 Million USD | 79.861% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | 54.735% |
| BioSig Technologies, Inc. | 18 Thousand USD | -46323.783% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 91.894% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | 38.62% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 99.059% |
| Axonics, Inc. | 274.55 Million USD | 96.956% |
| Outset Medical, Inc. | 29 Million USD | 71.185% |
| IRIDEX Corporation | 21.8 Million USD | 61.681% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 88.239% |
| IRadimed Corporation | 50.15 Million USD | 83.34% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -2811.596% |
| INVO Bioscience, Inc. | 1.08 Million USD | -669.357% |
| Telesis Bio, Inc. | 16.95 Million USD | 50.7% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 92.591% |
| Varex Imaging Corporation | 256.9 Million USD | 96.747% |
| Quipt Home Medical Corp. | 163.84 Million USD | 94.9% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 2158.197% |
| Pulmonx Corporation | 50.75 Million USD | 83.535% |
| Dynatronics Corporation | 7.63 Million USD | -9.447% |
| Modular Medical, Inc. | -768 Thousand USD | 1188.057% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -50.618% |
| Semler Scientific, Inc. | 61.2 Million USD | 86.346% |
| InMode Ltd. | 411.34 Million USD | 97.969% |
| Bruker Corporation | 1.51 Billion USD | 99.449% |
| Cytosorbents Corporation | 22.39 Million USD | 62.682% |
| DexCom, Inc. | 2.28 Billion USD | 99.635% |
| Align Technology, Inc. | 2.71 Billion USD | 99.693% |
| Viveve Medical, Inc. | 620 Thousand USD | -1247.787% |
| ZimVie Inc. | 290.38 Million USD | 97.122% |
| Movano Inc. | -158 Thousand USD | 5388.785% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 92.364% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -9723.984% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 97.727% |
| Profound Medical Corp. | 4.51 Million USD | -85.118% |
| Insulet Corporation | 1.15 Billion USD | 99.28% |
| enVVeno Medical Corporation | -546 Thousand USD | 1630.454% |
| Surmodics, Inc. | 93.05 Million USD | 91.02% |
| iCAD, Inc. | 14.53 Million USD | 42.513% |
| Nuwellis, Inc. | 4.98 Million USD | -67.696% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 97.482% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 2427.285% |
| InspireMD, Inc. | 1.8 Million USD | -362.439% |
| PAVmed Inc. | -3.96 Million USD | 310.592% |
| BIOLASE, Inc. | 16.72 Million USD | 50.034% |
| Beyond Air, Inc. | -1.3 Million USD | 739.348% |
| FONAR Corporation | 45.14 Million USD | 81.488% |
| AxoGen, Inc. | 127.87 Million USD | 93.465% |
| Vivani Medical, Inc. | -357 Thousand USD | 2440.695% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 95.718% |
| Inari Medical, Inc. | 434.56 Million USD | 98.077% |
| UFP Technologies, Inc. | 112.22 Million USD | 92.554% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -66648.79% |
| Tenon Medical, Inc. | 1.24 Million USD | -573.351% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 10416.396% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -218.081% |
| AdaptHealth Corp. | 479.56 Million USD | 98.258% |
| Sintx Technologies, Inc. | 1.84 Million USD | -353.406% |
| NanoVibronix, Inc. | 1.53 Million USD | -443.675% |
| Quanterix Corporation | 70.64 Million USD | 88.172% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 2158.197% |
| Sensus Healthcare, Inc. | 14.06 Million USD | 40.567% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 84.168% |
| TransMedics Group, Inc. | 154.09 Million USD | 94.577% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -87.655% |
| NeuroMetrix, Inc. | 3.94 Million USD | -111.69% |
| Hyperfine, Inc. | 4.75 Million USD | -75.663% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 92.189% |
| Biomerica, Inc. | 611 Thousand USD | -1267.64% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | 79.955% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 1170.008% |
| Silk Road Medical, Inc | 127.08 Million USD | 93.425% |